A direct supply of Bharat Biotech’s Covaxin has been commenced to 14 states with effect from May 1, said Suchitra Ella, company’s Joint Managing Director.
The Hyderabad-based firm has started supplying its Covid-19 treatment vaccine to the states based on the allocations received by the central government.
“Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24×7,” Ella tweeted.
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh, Delhi, Maharashtra and West Bengal.
On April 29, Bharat Biotech announced a cut in the price of ‘Covaxin’ for states to ₹400 per dose from the earlier ₹600 per dose.
This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
India has announced expansion of its Covid-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.
